SCHEMBL8690488

SCHEMBL8690488

CC(c1ccccc1)n1ccc2c(/C=C3\SC(=O)NC3=O)cccc21

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.53
MEN1 O00255 1/20 0.53
AKR1B1 P15121 1/20 0.53
KMT2A Q03164 1/20 0.53
PARP1 P09874 7/20 0.51
GSK3B P49841 1/20 0.46
IGF1R P08069 3/20 0.46
NAT1 P18440 1/20 0.46
PIM1 P11309 5/20 0.45
PIM3 Q86V86 3/20 0.45
PIM2 Q9P1W9 3/20 0.45
TDP2 O95551 1/20 0.43
CASP7 P55210 1/20 0.43
CASP9 P55211 1/20 0.43
CASP6 P55212 1/20 0.43
CASP8 Q14790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8811252 1.00 TTR (0.53) TTRMEN1AKR1B1KMT2APARP1
SCHEMBL8810441 0.89 TTR (0.55) TTRMEN1AKR1B1KMT2APARP1
SCHEMBL8685347 0.89 TTR (0.55) TTRMEN1AKR1B1KMT2APARP1
SCHEMBL8811257 0.87 MEN1 (0.40) TTRMEN1AKR1B1KMT2APARP1
SCHEMBL8685305 0.87 PARP1 (0.60) TTRMEN1AKR1B1KMT2APARP1
SCHEMBL8810704 0.87 PARP1 (0.60) TTRMEN1AKR1B1KMT2APARP1
SCHEMBL8685558 0.79 MEN1 (0.59) TTRMEN1AKR1B1KMT2APARP1
SCHEMBL8685562 0.79 MEN1 (0.59) TTRMEN1AKR1B1KMT2APARP1
SCHEMBL8686566 0.79 PARP1 (0.52) TTRMEN1AKR1B1KMT2APARP1
SCHEMBL8686570 0.79 PARP1 (0.52) TTRMEN1AKR1B1KMT2APARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed